Skip to content

The control group:Placebo

12 trials

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Dongzhimen Hospital, The First Affiliated Hospital of Beijing University of Chinese Medicine, Taizhou Hospital of Zhejiang Province, Tianjin First Central Hospital, Guangdong Provincial Hospital of Chinese Medicine

Conditions

Chronic Obstructive Pulmonary DiseaseChronic obstructive pulmonary, COPDIgA nephropathyPolycystic Ovarian SyndromePoor Ovarian ResponsSepsisThe cervical high risk HPV infectionchronic obstructive pulmonary disease

Early Phase 1

Phase 2

Phase 4

Unknown Phase

Clinical trials of Bao fu Kang Shuan for treatment of cervical high-risk HPV infection
Active, not recruitingChiCTR-TRC-14005087
Guangan men Hospital, China Academy of Chinese Medical SciencesThe cervical high risk HPV infection
Start: 2010-09-27Updated: 2017-04-18
The effect and security of high doses of spironolactone in protecting residual renal function of maintenance hemodialysis patients
Active, not recruitingChiCTR-IOR-15006906
Nephrology department of the first affiliated hospital of chengdu medical collegeuremia
Start: 2015-09-01Updated: 2017-04-18
A random, double-blind, well-compared study of safety and efficacy of Corbrin capsule vs placebo in the treatment of patient with COPD
RecruitingChiCTR-IOR-16009282
The First Affiliated Hospital of Guangzhou Medical UniversityChronic obstructive pulmonary, COPD
Start: 1990-01-01Updated: 2017-04-18
Clinical study of Shenci Formula on the treatment of precancerous lesions of gastric cancer
Active, not recruitingChiCTR-IOC-17013954
Guangdong Provincial Hospital of Chinese Medicineprecancerous lesion of gastric cancer
Start: 2018-01-01Updated: 2017-12-18
Based on microRNA, the targets and molecular mechanisms of Chinese traditional treatment to improve the quality of egg cells were investigated
RecruitingChiCTR1800019798
Affiliated Hospital of Shandong University of Traditional Chinese MedicinePoor Ovarian Respons
Start: 2018-12-01Updated: 2018-12-04
Multicenter randomized double-blind placebo-controlled clinical trial of Kushen gel in the treatment of persistent cervical high-risk HPV infection
Active, not recruitingITMCTR2025000214
Obstetrics & Gynecology Hospital of Fudan Universitypersistent cervical high-risk HPV infection
Start: 2025-03-01Updated: 2025-03-03

Related Papers